Frida Therapeutics

Fidra Therapeutics appears to be a very early-stage private biotechnology company operating under the legal name FIDRA THERAPEUTICS, INC., with evidence that it also uses the name FridaTX. Publicly available information is sparse, but trademark and corporate registration records indicate the company is focused on pharmaceutical research and development in biotechnology. Its stated disease focus includes autoimmune, inflammatory, and allergic diseases. No named drug candidates, disclosed molecular targets, clinical trials, or commercial products were identified in reliable public sources reviewed. Based on the limited evidence available, the company should be characterized as a stealth or minimally disclosed preclinical biotech.